Jefferies Group’s Immunic IMUX Stock Holding History

Jefferies Group’s Portfolio IMUX Stock Details IMUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$122K	Buy	+3,870	New	+$162K	﹤0.01%	1433
2019 Q1	–	Sell	-14	Closed	-$1K	–	2471
2018 Q4	$1K	Sell	14 -176	-93%	-$20.6K	﹤0.01%	2107
2018 Q3	$21K	Buy	+190	New	+$496K	﹤0.01%	2310
2018 Q2	–	Sell	-44	Closed	-$120K	–	2480
2018 Q1	$120K	Buy	+44	New	+$101K	﹤0.01%	2040
2016 Q2	–	Sell	-9	Closed	-$33K	–	2272
2016 Q1	$33K	Buy	9 +3	+50%	+$10.4K	﹤0.01%	2070
2015 Q4	$30K	Sell	6 -23	-79%	-$75.1K	﹤0.01%	2160
2015 Q3	$47K	Buy	+29	New	+$145K	﹤0.01%	2111

Other funds holding IMUX

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Jefferies Group's IMUX Position: Q3 2022 in Review

Jefferies Group opened a new position in Immunic (IMUX) in Q3 2022: 3,870 shares worth $122K. The stake represents ﹤0.01% of the portfolio and ranks #1433 among its holdings. This is a return to the name: Jefferies Group previously reported a position in IMUX as recently as Q4 2018.

Jefferies Group first reported a position in IMUX in Q3 2015 and has held it in 7 quarters since. 65 funds tracked by Wall St. Rank hold IMUX as of Q3 2022.

Jefferies Group held 3,870 shares of Immunic worth $122K as of Q3 2022.
Immunic was a new Jefferies Group position in Q3 2022.
Immunic made up ﹤0.01% of Jefferies Group's portfolio in Q3 2022, its #1433 holding.
Jefferies Group first reported a position in Immunic in Q3 2015 and has held it in 7 quarters since.
65 funds tracked by Wall St. Rank held Immunic as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.